Circulating metabolic markers after surgery identify patients at risk for severe postoperative complications: a prospective cohort study in colorectal cancer

dc.contributor.authorMontcusí, Blanca
dc.contributor.authorPera Román, Miguel
dc.contributor.authorMadrid Gambín, Francisco Javier
dc.contributor.authorPozo Mendoza, Óscar J., 1975-
dc.contributor.authorMarco Colás, Santiago
dc.contributor.authorMarín Martínez, Silvia
dc.contributor.authorMayol, Xavier
dc.contributor.authorPascual Damieta, Marta
dc.contributor.authorAlonso-Gonçalves, Sandra
dc.contributor.authorSilvia Salvans Ruiz
dc.contributor.authorJiménez-Toscano, Marta
dc.contributor.authorCascante i Serratosa, Marta
dc.date.accessioned2026-01-27T14:55:49Z
dc.date.available2026-01-27T14:55:49Z
dc.date.issued2024-03-01
dc.date.updated2026-01-27T14:55:49Z
dc.description.abstractBackground: Early detection of postoperative complications after colorectal cancer (CRC) surgery is associated with improved outcomes. The aim was to investigate early metabolomics signatures capable to detect patients at risk for severe postoperative complications after CRC surgery. Materials and methods: Prospective cohort study of patients undergoing CRC surgery from 2015 to 2018. Plasma samples were collected before and after surgery, and analyzed by mass spectrometry obtaining 188 metabolites and 21 ratios. Postoperative complications were registered with Clavien–Dindo Classification and Comprehensive Complication Index. Results: One hundred forty-six patients were included. Surgery substantially modified metabolome and metabolic changes after surgery were quantitatively associated with the severity of postoperative complications. The strongest positive relationship with both Clavien–Dindo and Comprehensive Complication Index (β=4.09 and 63.05, P<0.001) corresponded to kynurenine/tryptophan, against an inverse relationship with lysophosphatidylcholines (LPCs) and phosphatidylcholines (PCs). Patients with LPC18:2/PCa36:2 below the cut-off 0.084 µM/µM resulted in a sevenfold higher risk of major complications (OR=7.38, 95% CI: 2.82–21.25, P<0.001), while kynurenine/tryptophan above 0.067 µM/µM a ninefold (OR=9.35, 95% CI: 3.03–32.66, P<0.001). Hexadecanoylcarnitine below 0.093 µM displayed a 12-fold higher risk of anastomotic leakage-related complications (OR=11.99, 95% CI: 2.62–80.79, P=0.004). Conclusion: Surgery-induced phospholipids and amino acid dysregulation is associated with the severity of postoperative complications after CRC surgery, including anastomotic leakage-related outcomes. The authors provide quantitative insight on metabolic markers, measuring vulnerability to postoperative morbidity that might help guide early decision-making and improve surgical outcomes.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec743369
dc.identifier.issn1743-9191
dc.identifier.urihttps://hdl.handle.net/2445/226254
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1097/JS9.0000000000000965
dc.relation.ispartofInternational Journal of Surgery, 2024, vol. 110, num.3, p. 1493-1501
dc.relation.urihttps://doi.org/10.1097/JS9.0000000000000965
dc.rightscc-by (c) Montcusí, Blanca et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.classificationCàncer colorectal
dc.subject.classificationMetabolòmica
dc.subject.otherColorectal cancer
dc.subject.otherMetabolomics
dc.titleCirculating metabolic markers after surgery identify patients at risk for severe postoperative complications: a prospective cohort study in colorectal cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
844697.pdf
Mida:
498.59 KB
Format:
Adobe Portable Document Format